Advertisement Covers IAS 2015


Tribute to Bob Munk: Long-Time HIV-Positive U.S. Treatment Activist and Educator

July 20, 2015

Bob Munk

Bob Munk

It was with great sadness that in the week before IAS we learned of the death of Dr Robert Munk, a long-time US activist, friend and colleague.

We cannot remember a conference over almost twenty years that Bob did not attend, and of course he preceded us in this work by at least a decade. As a small tribute, our reports from IAS 2015 are dedicated to his work.

Bob was one of the first US activists that we met in the late 1990s while working at AIDS Treatment Project before we set up i-Base in April 2000.

Community meetings back then were often lively and Bob was notable for his steady calmness and kindness in interactions that could otherwise be energetic and sometimes volatile. The tributes that have followed his death have all focused on this gentleness and on his generosity to other activists.

Bob also worked internationally and was one of the few long-term US members of the European AIDS Treatment Group (EATG).

Since 1997, Bob started and developed The New Mexico AIDS Infonet resource ( of non-technical fact sheets that was unparalleled for both the breadth of the subjects and the insistence on writing for reading age of 12, so that even complex science issues were explained in everyday language. This was driven by the belief that all HIV positive people had a right to easy-to-understand, accurate and up-to-date information in order to be actively involved in decisions related to their own health care.

Just as importantly, the whole resource was updated in virtual real time as new data and research became available. For years a monthly email would detail all recent changes, so at a glance this was one of the most comprehensive ways to track developments. Just as impressively everything was produced in both English and Spanish.

Bob Munk at the speakers dinner for the Glasgow Conference in 2012, receiving an award from Professor Ian Weller, in recognition of his many years help with organising the conference.

Bob Munk at the speakers dinner for the Glasgow Conference in 2012, receiving an award from Professor Ian Weller, in recognition of his many years help with organising the conference.

Bob was first active in San Francisco following his diagnosis in 1987 and this experience informed his lifelong activism. This ranged from responding to individual treatment questions to early internet support forums such as the Crix-list and PI-treat to long-term involvement on scientific steering groups of international medical conferences, including the annual Lipodystrophy Workshop and the biannual Glasgow Congress. His encyclopaedic knowledge of HIV treatment history and his skill with carefully reporting evidence made his opinion an important voice in any debate.

For many years, Bob showed extraordinary resilience in continuing to attend and report from medical conferences despite increasing mobility difficulties related to a rare and difficult to treat neuromuscluar complications. He continued long after most of us would have settled for tracking everything online on webcasts. He also continued to travel despite many journeys needing three flight changes from his home in New Mexico.

Bob will be greatly missed and our thoughts are with his family and friends at this difficult time, especially with Enoch Ortega, his long-term partner and husband.

Links to other online tributes to Bob are included below from AVAC and

This article was provided by HIV i-Base. Visit HIV i-Base's website to find out more about their activities, publications and services.

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.